Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.13B | 1.06B | 1.02B | 992.00M | 969.00M |
| Total Depreciation and Amortization | 585.00M | 580.00M | 577.00M | 570.00M | 560.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 296.00M | 298.00M | 319.00M | 274.00M | 337.00M |
| Change in Net Operating Assets | -59.00M | -37.00M | -70.00M | 50.00M | 19.00M |
| Cash from Operations | 1.95B | 1.90B | 1.85B | 1.89B | 1.89B |
| Capital Expenditure | -576.00M | -554.00M | -524.00M | -527.00M | -492.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -89.00M | -122.00M | -139.00M | -101.00M | -434.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.00M | -2.00M | -5.00M | -3.00M | -16.00M |
| Cash from Investing | -646.00M | -678.00M | -668.00M | -631.00M | -942.00M |
| Total Debt Issued | 494.00M | 504.00M | 195.00M | 410.00M | 410.00M |
| Total Debt Repaid | -505.00M | -512.00M | -413.00M | -1.01B | -1.01B |
| Issuance of Common Stock | 126.00M | 118.00M | 115.00M | 79.00M | 82.00M |
| Repurchase of Common Stock | -593.00M | -593.00M | -490.00M | -495.00M | -345.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -369.00M | -363.00M | -357.00M | -353.00M | -347.00M |
| Other Financing Activities | -92.00M | -69.00M | -29.00M | -17.00M | -59.00M |
| Cash from Financing | -939.00M | -915.00M | -979.00M | -1.39B | -1.27B |
| Foreign Exchange rate Adjustments | -1.00M | -3.00M | 2.00M | 4.00M | -4.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 365.00M | 307.00M | 205.00M | -129.00M | -332.00M |